Senseonics Holdings Inc 2026年季度报告

FORM 10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the Quarterly Period Ended March31,2026or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934For the transition period from ______ to ______Commission file number: 001-37717 Senseonics Holdings, Inc.(Exact name of registrant as specified in its charter) (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Securities registered pursuant to Section 12(b) of theSecurities Exchange Act of 1934: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that theregistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data Filerequired to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “largeaccelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 ofthe Exchange Act. Largeacceleratedfiler☐Non-accelerated filer☒company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the ExchangeAct). Yes☐No☒ There were 41,802,965 shares of common stock, par value $0.001, outstanding as of May 4, 2026. TABLE OF CONTENTS PART I: Financial Information ITEM 1: Financial Statements Condensed Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and December 31,20253Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for thethree months ended March31,2026 and 20254Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the threemonths ended March 31, 2026 and 20255Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March31, 2026 and 20256Notes to Unaudited Condensed Consolidated Financial Statements7ITEM 2:Management’s Discussion and Analysis of Financial Condition and Results of Operations27ITEM 3:Quantitative and Qualitative Disclosures About Market Risk37ITEM 4:Controls and Procedures37PART II:Other Information38ITEM 1:Legal Proceedings38ITEM 1A: Risk Factors38ITEM 2:Unregistered Sales of Equity Securities and Use of Proceeds40ITEM 3:Defaults Upon Senior Securities40ITEM 4:Mine Safety Disclosures40ITEM 5:Other Information40ITEM 6:Exhibits41SIGNATURES43 Senseonics Holdings, Inc. Condensed Consolidated Balance Sheets(in thousands, except share and per share data) The accompanying notes are an integral part of these unaudited condensed consolidated financialstatements. Senseonics Holdings, Inc. Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss(in thousands, except share and per share data) The accompanying notes are an integral part of these unaudited condensed consolidated financialstatements. Senseonics Holdings, Inc. Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity(in thousands) The accompanying notes are an integral part of these unaudited condensed consolidated financialstatements. Senseonics Holdings, Inc. Unaudited Condensed Consolidated Statements of Cash Flows(in thousands) Senseonics Holdings, Inc. Notes to Unaudited Condensed Consolidated Financial Statements 1.Organization and Nature of Operations Business Senseonics Holdings, Inc., a Delaware corporation, is a medical technology company focused onthe design, development and commercialization of long-term, implantable continuous glucose monitoring(“CGM”) systems to improve the lives of people with diabetes by enhancing their ability to manage theirdisease with relative ease and accuracy. Senseonics, Incorporated is a wholly owned subsidiary of Senseonics Holdings, Inc. and wasoriginally incorporated on October 30, 1996, and commenced operations on January 15, 1997. Eon CareServices, LLC and Eon Management Services, LLC are wholly owned subsidiaries of Senseonics,Incorporated formed in April 2024 and July 2024, respectively. In connection with the transition ofcommercialization activities in Europe, the Company established wholly owned subsidiaries in Italy,Germany, S